Overview
Livagen (EDR) is a synthetic short-chain peptide bioregulator that targets liver tissue and modulates chromatin structure in aging somatic cells.
What problem it targets: It targets sluggish liver detoxification, hepatic inflammation, age-related chromatin compaction, immune weakness, and toxic liver burdens.
What It Does
• Promotes chromatin decondensation: Unpacks condensed, inactive DNA structures in aging cells, enabling cells to re-access dormant repair genes and synthesize vital proteins.
• Restores hepatic cellular vitality: Stimulates liver hepatocytes to repair cellular membranes and optimize Phase I and Phase II metabolic detoxification pathways.
• Modulates immune resilience: Preclinical studies show Livagen restores youthful functional activity to lymphocyte cells in elderly individuals.
• Realistic expectations: Run in short 10- to 20-day cycles a few times per year. Enhances internal liver health and cellular vitality without immediate sensory stimulation.
Reconstitution
| Vial Size | BAC Water / Solvent | Concentration |
|---|---|---|
| 20 mg (assumed vial strength) | 2 mL bacteriostatic water (requested mixing example) | 10 mg/mL = 10,000 micrograms/mL |
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Enter a target amount you already have and select the syringe capacity.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Presentation
20 mg vial used for the mixing example. Other sizes exist. Confirm the actual peptide content and sequence on the batch documentation.
Protocol
Community protocols & cycle timing
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Common community cycle pattern | 10–20 consecutive days; a few courses per year with months between courses | Compound- and formulation-specific; see rows below | A shared cycle duration does not establish one shared dose. Oral labels may specify 30-day initial courses or 10-day maintenance courses. |
| Community-reported course | 20-day course discussed; exact completed schedule not confirmed | 1 mg | Poster planned this course; follow-up described feeling wired initially, then settling. Other comments reported more energy without follow-up bloodwork. This is an anecdote, not a recommended regimen. |
Research study amounts
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Cultured human lymphocytes | Added after 24 hours; 72-hour culture endpoint | 0.01 microgram/mL | 2023 chromatin study. Laboratory exposure, not a human injection amount. |
About these protocols
The community rows describe reported experience, not a standard or recommended human regimen. Product-label rows apply to the cited formulation; cell and animal rows describe research models. The 20 mg / 2 mL table is a concentration example using the requested assumptions. Solvent compatibility and stability are product-specific.
Handling & Stacking
- Bioregulators are often discussed as short 10–20-day courses, repeated a few times a year with months between courses, rather than continuous daily use.
- This describes a community cycle pattern, not one universal dose.
- Some finished oral products instead specify a 30-day course or 10-day maintenance course.
- Where users report subcutaneous administration, the abdomen or outer thigh are common subcutaneous sites.
- This does not establish an approved administration route for this compound.
- No compound-specific universal storage temperature or post-mixing stability period was verified.
- Use the supplier’s stability data for that formulation.
- Keep identity, lot, preparation date and final concentration traceable; a purity percentage alone does not establish sterility or stability.
- The named preparation is not established here as an approved treatment for its marketed goals.
- Approved alternatives depend on the diagnosed condition and cannot be assigned from an organ label alone.
